The present study describes the development of a neurocognitive paradigm: “Assessing Neurocognition via Gamified Experimental Logic” (ANGEL), for performing the parametric evaluation of multiple neurocognitive functions simultaneously. ANGEL employs an audiovisual sensory motor design for the acquisition of multiple event related potentials (ERPs)—the C1, P50, MMN, N1, N170, P2, N2pc, LRP, P300, and ERN. The ANGEL paradigm allows assessment of 10 neurocognitive variables over the course of three “game” levels of increasing complexity ranging from simple passive observation to complex discrimination and response in the presence of multiple distractors. The paradigm allows assessment of several levels of rapid decision making: speeded up response vs. response-inhibition; responses to easy vs. difficult tasks; responses based on gestalt perception of clear vs. ambiguous stimuli; and finally, responses with set shifting during challenging tasks. The paradigm has been tested using 18 healthy participants from both sexes and the possibilities of varied data analyses have been presented in this paper. The ANGEL approach provides an ecologically valid assessment (as compared to existing tools) that quickly yields a very rich dataset and helps to assess multiple ERPs that can be studied extensively to assess cognitive functions in health and disease conditions.

No abstract

No abstract

We studied rats prenatally exposed to valproic acid (VPA), an established rodent model of autism. Both male and female VPA rats had a range of attentional impairments with sex-specific characteristics. Importantly, with fixed rules, graded difficulty levels, and more time, VPA rats could be successfully trained on the attentional task. Our work validates the use of the VPA model in the quest for evaluating suitable therapeutic targets for improving attentional performance.

Prior work in a Midwestern United States high tunnel indicated that hybrid and heirloom tomato scions grafted to hybrid rootstock ‘RST-04-106-T’ had a minimal yield increase in the absence of soilborne disease pressure, which underscored the need for continued regional trials of alternative, commercially available tomato rootstocks. Objectives of the present study were to assess yield, fruit quality [pH, soluble solids content (SSC), total titratable acids (TTA), and firmness], and plant growth traits (plant height, stem diameter, and biomass) of grafted tomato with eight different hybrid rootstocks. ‘BHN 589’, a determinate hybrid tomato, was grafted to ‘Arnold’, ‘Beaufort’, ‘DRO141TX’, ‘Estamino’, ‘Maxifort’, ‘RST-04-106-T’, and two trial rootstocks, ‘946 TRS’ and ‘980 TRS’. Research was conducted April to September in 2017 and 2018 in a 9.1-m wide × 29.2-m long × 3.7-m tall single-poly high tunnel located at the Iowa State University Horticulture Research Station, Ames, IA. There were five plants per treatment in a randomized complete block design with five replications. Weekly harvests took place 13 times each season. ‘BHN 589’ grafted to ‘Arnold’, ‘Beaufort’, ‘DRO141TX’, ‘Estamino’, or ‘Maxifort’ had 30% to 119% more marketable fruit and had a higher marketable fruit weight by 1.3 to 4.1 kg per plant compared with nongrafted plants. Fruit quality differences were minimal in 2017 and null in 2018, as indicated by fruit pH, SSC, TTA, and the SSC:TTA ratio. The same five high-yielding rootstock treatments were the tallest, ranging from 184 to 214 cm in height. In 2017, shoot biomass of ‘BHN 589’ grafted to ‘Arnold’, ‘Beaufort’, ‘DRO141TX’, ‘Estamino’, and ‘Maxifort’ was 59 to 100 g more than that of nongrafted plants; in 2018, ‘BHN 589’ grafted to ‘Maxifort’ and ‘DRO141TX’ had the largest shoot biomass at 386 and 315 g, respectively. Overall, the results of this study indicate that ‘Arnold’, ‘DRO141TX’, and ‘Estamino’ may be comparable in performance to the widely used rootstocks ‘Beaufort’ and ‘Maxifort’ when grown under conditions lacking biotic or abiotic stress. Our results provide promising new options for Midwestern U.S. growers of high tunnel tomato who are seeking high-performing rootstocks.

High tunnels allow vegetable growers to extend the growing season, increase crop production, and improve produce quality. Tomatoes (Solanum lycopersicum L.) are the most widely grown crops in high tunnels; however, tomato production in high tunnels can be challenging. Continuous cropping in high tunnels can increase soil-borne disease pressure and can lead to soil salinity or nutrient depletion issues. Based on preliminary research, we hypothesized that use of the rootstock 'RST-04-106-T' would increase yield and quality of heirloom and hybrid tomato scions compared with nongrafted plants. To test this hypothesis, our research objectives were to assess marketable yields, fruit quality and nutritional value, and plant growth of grafted and nongrafted hybrid and heirloom tomatoes in a high tunnel production system. Grafted and nongrafted 'Cherokee Purple' (heirloom) and 'Mountain Fresh Plus' (hybrid) tomatoes were grown in the same high tunnel for two seasons (

No abstract

Introduction Evidence from epidemiology, neuroimaging, and animal models indicates that asthma adversely affects the brain, but the nature and extent of neuropathophysiological impact remain unclear. Methods We tested the hypothesis that asthma is a risk factor for dementia by comparing cognitive performance and cerebrospinal fluid biomarkers of glial activation/neuroinflammation, neurodegeneration, and Alzheimer's disease (AD) pathology in 60 participants with asthma to 315 non‐asthma age‐matched control participants (45–93 years), in a sample enriched for AD risk. Results Participants with severe asthma had higher neurogranin concentrations compared to controls and those with mild asthma. Positive relationships between cardiovascular risk and concentrations of neurogranin and α‐synuclein were amplified in severe asthma. Severe asthma also amplified the deleterious associations that apolipoprotein E ε4 carrier status, cardiovascular risk, and phosphorylated tau 181 /amyloid beta 42 have with rate of cognitive decline. Discussion Our data suggest that severe asthma is associated with synaptic degeneration and may compound risk for dementia posed by cardiovascular disease and genetic predisposition. Highlights Those with severe asthma showed evidence of higher dementia risk than controls evidenced by: higher levels of the synaptic degeneration biomarker neurogranin regardless of cognitive status, cardiovascular or genetic risk, and controlling for demographics. steeper increase in levels of synaptic degeneration biomarkers neurogranin and α‐synuclein with increasing cardiovascular risk. accelerated cognitive decline with higher cardiovascular risk, genetic predisposition, or pathological tau.